---
title: "cancer_protocols"
date: "2024-09-05"
tags:
    - building
---

> [!NOTE]
> ðŸŒ± created from: [[cancer pharmacology]]

# cancer_protocols

- [[abvd.md|ABVD]]
- [[ac_paclitaxel.md|AC_Paclitaxel]]
- [[ac_docetaxel.md|AC_Docetaxel]]
- [[a-cmf.md|A-CMF]]
- [[ap_doxorubicin_cisplaitn.md|AP_Doxorubicin_Cisplaitn]]
- [[atc.md|ATC]]
- [[bendamustine.md|Bendamustine]] (CT)
- [[bevacizumab_folfiri.md|Bevacizumab_FOLFIRI]]
- [[bevacizumab_mfolfox6.md|Bevacizumab_mFOLFOX6]]
- [[caf.md|CAF]]
- [[cetuximab_folfiri.md|Cetuximab_FOLFIRI]]
- [[cetuximab_folfox4.md|Cetuximab_FOLFOX4]]
- [[chop.md|CHOP]]
- [[cmf.md|CMF]]
- [[cop.md|COP]]
- [[dc-breast_cancer.md|DC-breast cancer]]
- [[dc-lung_cancer.md|DC-lung cancer]]
- [[docetaxel_q3w.md|Docetaxel q3w]]
- [[docetaxel_weekly.md|Docetaxel Weekly]]
- DTIC (Dacarbazine)
- ELF
- [[ep.md|EP]]
- [[fluorouracil_leucovorin.md|Fluorouracil_Leucovorin]] (monthly)
- [[fluorouracil_leucovorin.md|Fluorouracil_Leucovorin]] (weekly)
- [[folfiri.md|FOLFIRI]]
- [[folfox4.md|FOLFOX4]]
- [[gc-bladder_cancer.md|GC-bladder cancer]] (åŒ–ç™‚)
- [[gc-ovarian_cancer.md|GC-ovarian cancer]]
- [[gp.md|GP]] (Gemcitabine_Paclitaxel)
- [[trastuzumab.md|Trastuzumab]]
- [[hd.md|HD]] (Trastuzumab_Docetaxel)
- [[hdfl.md|HDFL]] (2000/300 mg)
- [[mfolfox6.md|mFOLFOX6]]
- [[mvac.md|MVAC]]
- [[nab-paclitaxel-gemcitabine.md|Nab-paclitaxel-gemcitabine]]
- [[pcb.md|PCb]] (Paclitaxel_Carboplatin)
- [[pemetrexed.md|Pemetrexed]]
- [[pec.md|PeC]] (Pemetrexed+Cisplatin)
- [[pf.md|PF]] (3 days)
- [[pc.md|PC]] (Paclitaxel_Cisplatin)
- [[rituximab.md|Rituximab]]
- [[xelox.md|XELOX]] (CapeOX) q14days
- [[xelox.md|XELOX]] (CapeOX) q21days
